Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
06/2005
06/15/2005EP1541578A1 Process for selective production of aryl 5-thio-beta-d-aldohexopyranosides
06/15/2005EP1541576A1 Furoisoquinoline derivative and use thereof
06/15/2005EP1541574A1 Triazaspiro 5.5 undecane derivatives and drugs comprisi ng the same as the active ingredient
06/15/2005EP1541573A1 Novel crystals of triazaspiro 5.5 undecane derivative
06/15/2005EP1541571A1 Bicyclic unsaturated tertiary amine compound
06/15/2005EP1541564A1 Five-membered heterocyclic compounds
06/15/2005EP1541563A1 Ccr4 antagonist and medicinal use thereof
06/15/2005EP1541553A1 Novel indoline compound and medicinal use thereof
06/15/2005EP1541551A1 2-cyano-4-fluoropyrrolidine derivative or its salt
06/15/2005EP1541544A1 Method of preparing hydroxytyrosol esters, esters thus obtained and use of same
06/15/2005EP1541175A2 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
06/15/2005EP1541173A1 Method of degrading transcriptional factors of saccharometabolism-associated gene, method of inhibiting the degradation and degradation inhibitor
06/15/2005EP1541171A1 Therapeutics for diabetes mellitus
06/15/2005EP1541160A1 Body fat percentage-lowering agent or body fat percentage increase inhibitor
06/15/2005EP1541149A1 Phosphodiesterase inhibitor
06/15/2005EP1541037A1 Oral composition containing extracts of Passiflora incarnata
06/15/2005EP1539958A2 Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals
06/15/2005EP1539933A2 Methods of organ regeneration
06/15/2005EP1539931A1 Differentiation modulating agents and uses therefor
06/15/2005EP1539930A2 Multi-step method for the differentiation of insulin positive, glucose
06/15/2005EP1539928A2 Cd56 positive human adult pancreatic endocrine progenitor cells
06/15/2005EP1539769A1 Bicyclic heteroaromatic compounds as kinase inhibitors
06/15/2005EP1539763A1 Azaindole kinase inhibitors
06/15/2005EP1539760A2 Azapurine derivatives
06/15/2005EP1539748A1 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
06/15/2005EP1539746A1 N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes
06/15/2005EP1539742A1 Indole derivatives useful as histamine h3 antagonists
06/15/2005EP1539741A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
06/15/2005EP1539739A1 Piperidinyl compounds that selectively bind integrins
06/15/2005EP1539735A1 Piperazine urea derivatives as melanocortin-4 receptor agonists
06/15/2005EP1539732A1 Novel compounds
06/15/2005EP1539730A1 Novel compunds, pharmaceutical compositions containing same, and methods of use for same
06/15/2005EP1539729A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/15/2005EP1539707A1 Method and compounds for promoting healing and reducing inflammation
06/15/2005EP1539704A1 Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses
06/15/2005EP1539701A1 Caspase inhibitors and uses thereof
06/15/2005EP1539696A2 Process for preparing quinolin antibiotic intermediates
06/15/2005EP1539695A1 N-4-piperidinyl compounds as ccr5 modulators
06/15/2005EP1539694A1 2,3-dihydro-isoindol-1-ones with mao-b inhibiting activity
06/15/2005EP1539693A1 Cannabinoid receptor agonists
06/15/2005EP1539689A2 Antisense modulation of endothelial lipase expression
06/15/2005EP1539686A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
06/15/2005EP1539674A1 Amino-propanol derivatives
06/15/2005EP1539662A1 Cannabinoid receptor ligands
06/15/2005EP1539232A1 Immunization against autologous ghrelin
06/15/2005EP1539217A2 Methods for identification of compounds modulating insulin resistance
06/15/2005EP1539216A2 Labelled somatostatin analogs backbone cyclized through metal complexation
06/15/2005EP1539195A2 Use of prebiotics for the treatment and prevention of hyperglycaemic syndromes
06/15/2005EP1539175A2 Substituted indolealkanoic acids derivative and formulations containing same for use in treatment of diabetic complications
06/15/2005EP1539158A1 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia
06/15/2005EP1539153A2 Therapeutic treatment for the metabolic syndrome and type 2 diabetes
06/15/2005EP1539137A1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
06/15/2005EP1539136A2 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
06/15/2005EP1539129A1 Dosage forms and related therapies
06/15/2005EP1539120A1 Combination of an ibat inhibitor and a metal salt for the treatment of diarrhoea
06/15/2005EP1538913A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
06/15/2005EP1448560B1 3-SUBSTITUTED OXINDOLE beta 3 AGONISTS
06/15/2005EP1439831B1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
06/15/2005EP1373240B1 Retinoid x receptor modulators
06/15/2005EP1349856B1 Isoindolin-1-one glucokinase activators
06/15/2005EP1311504B1 Tetrazolyl-phenyl acetamide glucokinase activators
06/15/2005EP1305301B1 Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
06/15/2005EP1257277B1 New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent
06/15/2005EP1248836B1 Method for preparing vaccines by using hybrid cells
06/15/2005EP1248785B1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
06/15/2005EP1114031B1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
06/15/2005EP1007068B1 Process for preparing synthetic soil-extract materials and medicaments based thereon
06/15/2005EP0998556B1 Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1)
06/15/2005EP0996732B1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
06/15/2005EP0991654B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same
06/15/2005EP0977564B1 Forskolin for promoting lean body mass
06/15/2005CN1628116A Inhibitors of alpha l beta 2 integrin mediated cell adhesion
06/15/2005CN1628111A 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
06/15/2005CN1628109A Novel aryl- and heteroarylpiperazines
06/15/2005CN1628102A Pyridineamido derivatives as inhibitors of monoamine oxidase (MAO-B)
06/15/2005CN1628101A 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
06/15/2005CN1628088A Novel 3-aryl-2,5-dihydroxy-1,4-benzoquinone derivatives, their preparation method and pharmaceutical compositions containing same
06/15/2005CN1627954A Pharmaceutical compsn. contg. extract from barleria prionitis linn and its process of prepn
06/15/2005CN1627945A Quinoline derivatives as NPY antagonists
06/15/2005CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
06/15/2005CN1626655A Synthetase-1b for human cholesterol ester and coded sequence
06/15/2005CN1626521A Acceptor excitant of a class of pancreas hyperglycemia peptide-1, preparation method and usage
06/15/2005CN1626221A Combination of medication
06/15/2005CN1626211A Astragalus-leech preparation of lowering blood sugar for treating diabetes and syndrome and preparation method
06/15/2005CN1626208A Preparation of fleabane and preparation method
06/15/2005CN1626199A Powder injection preparation for generating channels and vessels, and preparation method
06/15/2005CN1626183A Pure natural health care capsule for female
06/15/2005CN1626177A Powder injection of astragalus root and preparation method
06/15/2005CN1626176A Medication for treating diabetes
06/15/2005CN1626175A Big bitter gourd in application for preparing medication
06/15/2005CN1626173A Sugarless type oral liquid of rehmannia root including six elements
06/15/2005CN1626166A Prepared Chinese medicine in use for treating diabetes
06/15/2005CN1626163A Chinese traditional medicine for treating diabetes
06/15/2005CN1626157A Method for preparing oral liquid for lowering blood sugar
06/15/2005CN1626128A Medicine for treating diabetes
06/15/2005CN1626108A Acarbose enteric coated tablets and its prepn. method
06/15/2005CN1626099A Extractive of 'Zong'wood for treating diabetes, and application of saponin of 'Zong' wood for treating diabetes
06/15/2005CN1626095A Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
06/15/2005CN1626070A Effect of aminoguanidine for curing wound surface in refractory to treatment
06/15/2005CN1626069A Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
1 ... 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 ... 1298